- The platform received unprecedented regulatory approval to function as a primary care provider without direct human oversight for routine diagnoses
- Co-CEO Dr. Adam Oskowitz stated the system is designed to address the critical shortage of medical professionals by automating clinical decision-making
- The authorization allows the AI to prescribe medications and order diagnostic tests across multiple state jurisdictions
- Medical ethics experts have raised concerns regarding liability and the potential for algorithmic bias in autonomous clinical settings
- Market analysts predict this milestone will trigger a significant shift in healthcare venture capital toward fully autonomous AI-native care models
Doctronic becomes first AI system legally authorized to practice medicine in the United States
Mar 31, 2026, 2:54:26 PM UTC(5 hours ago)
Impact: Medium
Affected Assets
Sources
From:@YahooFinance
AI-native care platform Doctronic becomes the first AI system legally authorized to practice medicine in the US.
💊 “There’s just not enough doctors to meet the demands of patients, and we need to use technology to improve that,” co-CEO Dr. Adam Oskowitz says. https://t.co/4VmAGNet97
